LifeMD [LFMD] vs Veeva Systems [VEEV] Detailed Stock Comparison

LifeMD Inc.

NASDAQ
Loading...

Veeva Systems Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: LifeMD Inc. wins in 2 metrics, Veeva Systems Inc. wins in 16 metrics, with 0 ties. Veeva Systems Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric LifeMD Inc. Veeva Systems Inc. Better
P/E Ratio (TTM) N/A 29.57 N/A
Price-to-Book Ratio 9.31 3.66 Veeva Systems Inc.
Debt-to-Equity Ratio 27.31 1.33 Veeva Systems Inc.
PEG Ratio 10.38 1.22 Veeva Systems Inc.
EV/EBITDA -27.85 20.16 Veeva Systems Inc.
Profit Margin (TTM) 7.40% 28.45% Veeva Systems Inc.
Operating Margin (TTM) -2.34% 29.41% Veeva Systems Inc.
EBITDA Margin (TTM) N/A 29.41% N/A
Return on Equity -131.16% 13.93% Veeva Systems Inc.
Return on Assets (TTM) -6.54% 7.25% Veeva Systems Inc.
Free Cash Flow (TTM) $-1.24M $1.42B Veeva Systems Inc.
1-Year Return -64.95% -37.67% Veeva Systems Inc.
Price-to-Sales Ratio (TTM) 1.14 8.29 LifeMD Inc.
Enterprise Value $186.86M $19.85B Veeva Systems Inc.
EV/Revenue Ratio 0.96 6.21 LifeMD Inc.
Gross Profit Margin (TTM) 40.22% 74.46% Veeva Systems Inc.
Revenue per Share (TTM) $4 $20 Veeva Systems Inc.
Earnings per Share (Diluted) $-0.30 $5.45 Veeva Systems Inc.
Beta (Stock Volatility) 1.77 1.10 Veeva Systems Inc.
Short % of Float 15.82% 3.90% Veeva Systems Inc.

LifeMD Inc. vs Veeva Systems Inc. Stock Performance Analysis

Loading Price Chart...

LFMD
VEEV

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
LifeMD Inc.-2.77%10.61%-7.86%61.17%31.74%34.38%
Veeva Systems Inc.-2.31%15.39%7.47%0.82%-23.82%-16.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
LifeMD Inc.-64.95%100.00%-68.48%217.04%350.53%350.53%
Veeva Systems Inc.-37.67%-10.59%-39.53%399.40%292.75%292.75%

Performance & Financial Health Analysis: LifeMD Inc. vs Veeva Systems Inc.

MetricLFMDVEEV
Market Information
Market Cap i$217.80M$26.49B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i1,527,6182,223,070
90 Day Avg. Volume i1,311,0162,094,990
Last Close$4.56$178.72
52 Week Range$2.56 - $15.84$148.05 - $310.50
% from 52W High-71.21%-42.44%
All-Time High$33.02 (Feb 08, 2021)$343.96 (Aug 02, 2021)
% from All-Time High-86.19%-48.04%
Growth Metrics
Quarterly Revenue Growth-0.27%0.16%
Quarterly Earnings Growth-0.89%0.25%
Financial Health
Profit Margin (TTM) i0.07%0.28%
Operating Margin (TTM) i-0.02%0.29%
Return on Equity (TTM) i-1.31%0.14%
Debt to Equity (MRQ) i27.311.33
Cash & Liquidity
Book Value per Share (MRQ)$0.50$44.05
Cash per Share (MRQ)$0.77$40.17
Operating Cash Flow (TTM) i$8.28M$1.42B
Levered Free Cash Flow (TTM) i$-10,155,929$1.05B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: LifeMD Inc. vs Veeva Systems Inc.

MetricLFMD (Apr 24, 2026)VEEV (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A29.57
Forward P/E i10.3816.30
PEG Ratio i10.381.22
Price to Sales (TTM) i1.148.29
Price to Book (MRQ) i9.313.66
Market Capitalization
Market Capitalization i$217.80M$26.49B
Enterprise Value i$186.86M$19.85B
Enterprise Value Metrics
Enterprise to Revenue i0.966.21
Enterprise to EBITDA i-27.8520.16
Risk & Other Metrics
Beta i1.771.10
Book Value per Share (MRQ) i$0.50$44.05

Financial Statements Comparison: LifeMD Inc. vs Veeva Systems Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLFMD (2025)VEEV (2026)
Revenue/Sales i194.06M3.20B
Cost of Goods Sold i27.71M782.02M
COGS % of Revenue i14.3%24.5%
Gross Profit i166.34M2.41B
Gross Margin i85.7%75.5%
Research & Development i7.35M767.39M
Operating Income (EBIT) i-7.67M916.37M
Operating Margin i-4.0%28.7%
EBITDA i-361,236944.36M
EBITDA Margin i-0.2%29.6%
Pre-Tax Income i-10.19M1.19B
Pre-Tax Income % of Revenue i-5.2%37.4%
Income Tax i45,721285.60M
Income Tax % of Revenue i0.0%8.9%
Net Income (Profit) i15.62M908.91M
Profit Margin i8.0%28.4%

Balance Sheet & Liquidity Metrics

MetricLFMD (2025)VEEV (2026)
Cash & Equivalents i36.79M1.42B
Total Current Assets i51.83M8.00B
Total Current Assets % of Revenue i26.7%250.3%
Total Current Liabilities i41.57M1.64B
Total Current Liabilities % of Revenue i21.4%51.2%
Long-Term Debt i5.68M83.71M
Long-Term Debt % of Revenue i2.9%2.6%
Total Shareholders Equity i23.16M7.21B
Retained Earnings i-228.60M4.36B
Retained Earnings % of Revenue i-117.8%136.6%
Property, Plant & Equipment i5.27M0

Cash Flow Statement Comparison

MetricLFMD (2025)VEEV (2026)
Operating Cash Flow i6.98M1.46B
Operating Cash Flow % of Revenue i3.6%45.6%
Capital Expenditures i-1.87MN/A
Free Cash Flow i-1.24M1.42B
FCF Margin i-0.6%44.3%
Debt Repayment i-18.72MN/A
Common Stock Repurchase iN/A-169.95M

Short Interest & Institutional Ownership Analysis

MetricLFMDVEEV
Shares Short i6.24M5.82M
Short Ratio i4.522.75
Short % of Float i15.82%3.90%
Shares Outstanding i46.66M163.78M
Float Shares i39.76M149.83M
% Held by Insiders i15.08%8.57%
% Held by Institutions i39.70%89.44%
% Held by Public i45.22%1.99%

Dividend Analysis & Yield Comparison: LifeMD Inc. vs Veeva Systems Inc.

MetricLFMDVEEV
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A